[Success and prospects in the therapy of heart failure in children].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000378:metabolism / Q000627:therapeutic use; D002648:Child; D004232:Diuretics / Q000627:therapeutic use; D004341:Drug Evaluation; D005934:Glucagon / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007700:Kinetics; D011485:Protein Binding / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002301:Cardiac Glycosides; D004232:Diuretics; D005938:Glucocorticoids; D014665:Vasodilator Agents; D005934:Glucagon
Uspekhi i perspektivy v lechenii serdechnoĭ nedostatochnosti u deteĭ.